4//SEC Filing
Thompson Matthew 4
Accession 0001013606-19-000169
CIK 0001013606other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:30 PM ET
Size
10.4 KB
Accession
0001013606-19-000169
Insider Transaction Report
Form 4
Thompson Matthew
Chief Medical Officer
Transactions
- Disposition to Issuer
Option to Purchase
2019-09-27−8,999→ 0 totalExercise: $48.20From: 2017-06-30Exp: 2027-05-31→ Common Stock (8,999 underlying) - Award
Option to Purchase
2019-09-27+6,304→ 6,304 totalExercise: $4.71From: 2020-09-10Exp: 2026-09-10→ Common Stock (6,304 underlying) - Disposition to Issuer
Option to Purchase
2019-09-27−9,907→ 0 totalExercise: $69.10From: 2017-12-01Exp: 2026-12-01→ Common Stock (9,907 underlying)
Footnotes (4)
- [F1]Options vest ratably over forty-eight months.
- [F2]The issuer cancelled, pursuant to the issuer's option exchange program which expired on September 9, 2019, (i) an option for 8,999 shares of common stock granted to the reporting person on May 31, 2017, and (ii) an option for 9,907 shares of common stock granted to the reporting person on December 1, 2016. In exchange, the reporting person received a new stock option, for 6,304 shares, having an exercise price of $4.71 per share, which is equal to the closing price per share of the common stock on the NASDAQ Global Market on September 10, 2019.
- [F3]Twenty-five percent of the options vested upon one year of service and the remaining balance continued to vest in equal monthly installments thereafter.
- [F4]The options vest in three equal annual installments over a three-year period commencing on September 10, 2019.
Documents
Issuer
ENDOLOGIX INC /DE/
CIK 0001013606
Entity typeother
Related Parties
1- filerCIK 0001740988
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 4:30 PM ET
- Size
- 10.4 KB